The American Thyroid Association 2025 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum Task Force led by Co-chairs, Tim Korevaar, MD, PhD and Angela Leung, MD, has completed its work on the guideline manuscript.
We are now opening a 30-day comment period for ATA Members and Leadership. Please submit your comments in the form below by Sunday, June 29, 2025 for consideration by the task force prior to submission for peer-review and publication in Thyroid®.
Please see links below for manuscripts and key supplements.
Guideline Draft: American Thyroid Association 2025 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum
Supplementary Table 1. Overview of literature used for recommendations
Supplementary Table 2. Details for all systematic literature searches
Please Note – This revision is not yet peer reviewed and should not be distributed outside the ATA membership.
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.